In a significant breakthrough for patients living with thyroid eye disease (TED), the UK’s Medicines and Healthcare products Regulatory...
Read MoreiOnctura, a clinical-stage biopharmaceutical company, has announced the launch of a phase 1/2 clinical trial investigating its lead asset,...
Read MoreIn a landmark moment for artificial intelligence in healthcare, the National Institute for Health and Care Excellence (NICE) has...
Read MoreIn a significant development for the treatment of advanced Hodgkin lymphoma, Takeda has announced that the Committee for Medicinal...
Read MoreIn a bold stride for Irish healthcare, a five-year clinical study aimed at revolutionising childhood cancer treatment has officially...
Read MorePatients suffering from transthyretin amyloid cardiomyopathy (ATTR-CM) now have new hope, as the Medicines and Healthcare products Regulatory Agency...
Read More